Download:
pdf |
pdf44796
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. CDC plans to revise this
application to:
(1) Based on processing applications,
remove questions that duplicative or not
required to process the import permit
request such as CDC plans to revise this
application to request information on
where the imported material will be
stored at the recipient facility and who
would be responsible for this location
and revise the format for the form to
ease of user to complete the form.
(2) Request information the biosafety
officer’s contact information for the
permittee to provide biosafety
information in case the permittee is
unavailable.
operated by government agencies,
universities, research institutions, and
for educational, exhibition, or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
isolation and containment information.
CDC plans to revise this application to
add a question about what personal
protective measures will be used. This
additional data request will not affect
the burden hours.
Estimates of burden for the survey are
based on information obtained from the
CDC import permit database on the
number of permits issued on annual
basis since 2010. The total estimated
burden for the one-time data collection
is 1592.
There are no costs to respondents
except their time.
These additional data requests will
not affect the burden hours.
In addition, CDC proposes to revise
the Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form to verify that the
recipient for subsequent transfers has
implemented biosafety measures
commensurate with the hazard posed by
the infectious biological agent,
infectious substance, and/or vector to be
imported, and the level of risk given its
intended use. CDC believes that it will
take the applicant additional 10 minutes
to complete this section for subsequent
transfers. Estimates of burden for the
additional questions survey are based
on information obtained from the CDC
import permit database on the number
of permits issued for 2016 for
subsequent transfers, which is 380
permits.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
2380
1
30/60
1190
2380
1
10/60
397
Applicants Requesting to Import Live
Bats.
Applicants Requesting to Import Live
Bats.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States
Guidance.
Application for a Permit to Import
Live Bats.
Application for a Permit to Import
Live Bats.
10
1
20/60
3
10
1
10/60
2
Total ...........................................
..........................................................
........................
........................
........................
1592
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–20509 Filed 9–25–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–17HO]
Agency Forms Undergoing Paperwork
Reduction Act Review
BILLING CODE 4163–18–P
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
VerDate Sep<11>2014
18:28 Sep 25, 2017
Jkt 241001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
E:\FR\FM\26SEN1.SGM
26SEN1
44797
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Test Predictability of Falls Screening
Tools—New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Falls are the leading cause of fatal and
nonfatal injuries among adults aged 65
and older in the US and represent a
significant burden to the healthcare
system. The first step in clinical falls
prevention is for health care
practitioners to administer a fall risk
screening. The screening identifies
whether adults 65 and older are at
‘‘increased risk’’ for a fall. Additional
assessments and follow-up medical care
(e.g., medication review, vitamin D
supplements, vision testing, and
physical therapy) are then given to those
at increased risk. The initial screening
step is critical because it identifies who
will receive the assessments and followup care, which has the potential to place
a large burden on health care
practitioners and the health care system.
Given the demands on health care
practitioners, among them to reduce
health care costs, it is important to have
a screening tool that can reliably
identify adults 65 and older who are
likely to fall and thus need this
additional care. Although there are a
number of tools used to screen older
adults for fall risk, there is currently no
standard for fall risk screening across
care settings. This is in part because
many of the existing tools have never
been tested to determine how well they
predict future falls. Thus, research is
needed to test the ability of existing
screening tools and questions to predict
falls in subsequent years.
The proposed data collection will
compile a brief set of screening
questions that are clinically useful for
quickly sorting patients into risk levels
for falls. It is expected that the screening
questions identified in this project will
be recommended for use by CDC as the
standard for screening of falls for adults
65 and older in clinical settings.
Questions will be asked to a nationally
representative sample of adults 65 and
older, who will then be followed with
surveys repeated monthly over the
following year to determine whether
and how often they fall. Study data will
be collected by internet or phone
interviews, depending on respondents’
preference. Interviews will consist of a
baseline survey beginning immediately
after OMB approval, 11 brief monthly
update surveys for the 11 months after
initial survey, and a final survey
(similar in content to the baseline
survey) 12 months after initial survey.
At baseline, exploratory factor
analysis and confirmatory factor
analysis will be used to demonstrate
which survey items have the greatest
likelihood of predicting future falls. To
narrow down the larger list of survey
items, item response theory will be
used. Descriptive data analysis
techniques will be used at every data
collection time point in order to clean
the data and to look for trends and
outliers. Univariate and multivariate
data analysis (primarily logistic
regression) techniques will be used at 6
and 12 months after initial survey in
order to determine which survey
questions are related to fall status with
statistical significance and to identify
which survey questions have the
greatest likelihood of predicting fall
status while considering whether
separate tools are necessary for key
subgroups at high risk for falls, such as
women and persons with prior history
of falls.
OMB approval is requested for two
years for this new collection. Findings
from this data collection will be used to
examine the predictability (sensitivity
and specificity) of various sets of
screening questions on the occurrence
of falls, including medically treated
falls. The estimated annual burden
hours are 2,970. There are no costs to
respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Participating AmeriSpeak Panelists ................
Initial Postcard-Email .....................................
Baseline Survey Web Mode ..........................
Baseline Survey Phone Mode .......................
Monthly Update Survey (months 1–11) Web
Mode.
Monthly Update Survey (months 1–11)
Phone Mode.
Final Survey Web Mode ................................
Final Survey Phone Mode .............................
Falls Diary ......................................................
Proxy Survey Web Mode ...............................
Proxy Survey Phone Mode ............................
Proxy Respondents .........................................
VerDate Sep<11>2014
18:28 Sep 25, 2017
Jkt 241001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\26SEN1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
1,463
570
380
570
1
1
1
11
2/60
20/60
30/60
10/60
380
11
15/60
570
380
276
57
38
1
1
2
4
4
20/60
30/60
5/60
3/60
5/60
26SEN1
44798
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–17–1053; Docket No. CDC–2017–
0079]
[FR Doc. 2017–20507 Filed 9–25–17; 8:45 am]
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
Centers for Disease Control and
Prevention
[CDC–2015–0021; Docket Number NIOSH–
153–C]
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on Monitoring and Reporting
System for the Division of Community
Health’s Cooperative Agreement
Programs. CDC seeks to continue the
collection of information from awardees
funded through the Racial and Ethnic
Approaches to Community health
(REACH) cooperative agreement to
provide semi-annual reports to CDC
describing their work plan, activities
and progress toward achieving
objectives during the fourth year of
funding.
SUMMARY:
Final Skin Notation Profiles
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability.
AGENCY:
NIOSH announces the
availability of the following 9 Skin
Notation Profile documents: 1Bromopropane [CAS No. 106–94–5],
Disulfoton [CAS No. 298–04–4],
Heptachlor [CAS No. 76–44–8], 2Hydropropyl acrylate [CAS No. 999–61–
1], Trichloroethylene [CAS No. 79–01–
7], Tetraethyl lead [CAS No. 78–00–2],
Tetramethyl lead [CAS No. 75–74–1],
Dimethyl sulfate [CAS No. 77–78–1],
Arsenic and compounds [CAS No.
7440–38–2].
DATES: The final Skin Notation Profile
documents were published on August
17, 2017.
ADDRESSES: These documents may be
obtained at the following link: http://
www.cdc.gov/niosh/topics/skin/skinnotation_profiles.html.
FOR FURTHER INFORMATION CONTACT:
Naomi Hudson, Dr. Ph.D., NIOSH,
Education and Information Division
(EID), Robert A. Taft Laboratories, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, phone 513/533–8388 (not a
toll-free number), email: [email protected].
SUPPLEMENTARY INFORMATION: On May 1,
2015, NIOSH published a request for
public review in the Federal Register
[80 FR 24932] on skin notation profiles
and technical documents. All comments
received were reviewed and addressed
where appropriate.
SUMMARY:
Dated: September 18, 2017.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2017–20126 Filed 9–25–17; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
21:09 Sep 25, 2017
Jkt 241001
Written comments must be
received on or before November 27,
2017.
DATES:
You may submit comments,
identified by Docket No. CDC–2017–
0079 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
ADDRESSES:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the
address listed above.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\26SEN1.SGM
26SEN1
File Type | application/pdf |
File Modified | 2017-09-26 |
File Created | 2017-09-26 |